Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Adagene Inc
Scientific Title
First-in-human (FIH), Open-Label, Phase I (Dose Escalation) Study of ADG116 in Patients With Advanced/Metastatic Solid Tumors